Image of coronavirus related symbols including tablet and handwashing to show Mobile coronavirus testing units for frontline workers

Mobile coronavirus testing units for frontline workers

Mobile coronavirus testing units, operated by the Armed Forces, will travel around the UK to increase access to coronavirus testing. Essential workers and the most...
Image of blue and white block being stacked to show New collaboration to identify COVID-19 target receptors

New collaboration to identify COVID-19 target receptors

Medicines Discovery Catapult, Retrogenix and Peak Proteins are collaborating to identify COVID-19 target receptors to advance understanding of the cellular mechanisms of infection by...
Image of a syringe and coronavirus to show MHRA approves COVID-19 vaccine trial in 7 working days

MHRA approves COVID-19 vaccine trial in 7 working days

In its commitment to prioritising potential treatments for COVID-19, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the COVID-19 Oxford Vaccine Trial request...
Image of a laptop with medical charts and tablets around ti to show Medicspot rolls out remote COVID-19 diagnosis system

Medicspot rolls out remote COVID-19 diagnosis system

Medicspot is rolling out the technology for remote COVID-19 diagnosis to protect staff and patients amid the COVID-19 outbreak. Working in partnership with clinical commissioning...
Image of hospital equipment and monitor to show NICE coronavirus guidelines on gastrointestinal and liver conditions and acute myocardial injuries

NICE coronavirus guidelines on gastrointestinal and liver conditions and acute myocardial injuries

NICE has published two new rapid coronavirus guidelines on the care of patients with suspected and confirmed COVID-19. They cover the management of disorders of...
Image of a PPE mask to show IQVIA collaborates to launch accelerated COVID-19 infection survey

IQVIA collaborates to launch accelerated COVID-19 infection survey

IQVIA has joined forces with the Office for National Statistics (ONS), Oxford University and UK Biocentre to launch an accelerated COVID-19 infection survey. They will...
Image of coronvirus to show Government launches coronavirus vaccine taskforce as human clinical trials start

Government launches coronavirus vaccine taskforce as human clinical trials start

The UK Government has launched a new coronavirus vaccine taskforce to drive forward, expedite and co-ordinate efforts to research and then produce a coronavirus vaccine....
Image f a man and woman shaking hands to show NICE recommends VITRAKVI ® for children and adults with TRK fusion driven cancer

NICE recommends VITRAKVI® for children and adults with TRK fusion driven cancer

Bayer announced that VITRAKVI® (larotrectinib) was recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of advanced neurotrophic tyrosine...
Image of a bag of blood to show Coronavirus convalescent plasma clinical trial

Coronavirus convalescent plasma wanted for clinical trial

The NHS Blood and Transplant Service is asking for people who’ve recovered from coronavirus (COVID-19) to donate blood plasma, as part of a potential clinical...
Image of a magnifying glass over coronavirus to show Novartis sponsors hydroxychloroquine clinical trial in hospitalised COVID-19 patients

Novartis sponsors hydroxychloroquine clinical trial in hospitalised COVID-19 patients

Novartis has announced that it is to sponsor a large hydroxychloroquine clinical trial in hospitalised COVID-19 patients. Novartis has reached an agreement with the US...

Latest articles

First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

The world’s first Alzheimer’s disease (AD) drug candidate designed by artificial intelligence (AI) is entering Phase I clinical trials, thanks to a successful collaboration...
Colin Prentice, Commercial Director at Evolve

Expand and evolve – when specialist services meet

Specialist recruitment and outsourcing consultancy, Evolve, is pleased to announce the integration of Prentice Associates Ltd. The two specialist organisations have both provided recruitment...
NHS launches £160m initiative to tackle waiting lists

NHS launches £160m initiative to tackle waiting lists

The NHS has announced a £160 million initiative to tackle waiting lists and develop a blueprint for elective recovery as early reports show the...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

The world’s first Alzheimer’s disease (AD) drug candidate designed by artificial intelligence (AI) is entering Phase I clinical trials, thanks to a successful collaboration...
Diane DiGangi Trench appointed UK Country Head of Sandoz

Sandoz appoints new UK Country Head

Sandoz has announced the appointment of Diane DiGangi Trench, as its UK Country Head. Previously Vice-President, Market Access and Patient Services at Sandoz in the...
Colin Prentice, Commercial Director at Evolve

Expand and evolve – when specialist services meet

Specialist recruitment and outsourcing consultancy, Evolve, is pleased to announce the integration of Prentice Associates Ltd. The two specialist organisations have both provided recruitment...
NHS launches £160m initiative to tackle waiting lists

NHS launches £160m initiative to tackle waiting lists

The NHS has announced a £160 million initiative to tackle waiting lists and develop a blueprint for elective recovery as early reports show the...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription